Prepar ations of 6-phytase A (EC 3.1.3.26) and phytase B (acid phosphatase, EC 3.1.3.2) were applied alone and combined in the preparation of dough to estimate their catalytic potential for myo-inositol liberation from rye fl our in the breadmaking technology. The experimental bread samples were ground a er baking and subjected to determination of myo-inositol bioavailability by an in vitro method that simulated digestion in a human alimentary tract, followed by measurements of myo-inositol transport through enterocyte--like diff erentiated Caco-2 cells to determine its bioaccessibility. Myo-inositol content was measured by a high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) technique. The concentration of myo-inositol in the dialysates of control bread was 25.3 µg/mL, whereas in the dialysates of bread sample baked with 6-phytase A, the concentration increased to 35.4 µg/mL, and in the bread baked with phytase B to 64.98 µg/mL. Simultaneous application of both enzymes resulted in myo-inositol release of 64.04 µg/mL. The highest bioaccessibility of myo-inositol, assessed by the measurement of the passage through the Caco-2 monolayer was determined in the bread baked with the addition of 6-phytase A. Enzymatically modifi ed rye bread, particularly by the addition of 6-phytase A, may be therefore a rich source of a highly bioaccessible myo--inositol.
Introduction
Phytic acid (1,2,3,4,5,6-myo-inositol hexakisphosphate) is diffi cult to digest in the gastrointestinal tract of monogastric animals and humans, and is therefore considered as an antinutritional factor because it reduces bioavailability of minerals, proteins and starch (1) . Enzymatic methods of phytate degradation in foods and feeds have gained considerable interest, regarding their numerous advantages over physical or chemical methods (2) . Phyta ses, phosphohydrolases of myo-inositol hexakisphosphate, hydrolyse phytate to a pool of lower myo-inositol phosphates (3, 4) . In breadmaking, phosphorolytic activity originates from wheat or rye fl our enzymes as well as from the yeast phytase (5) (6) (7) . The joint action of these enzymes determines the fi nal profi le of inositol phosphates and may also lead to the formation of free myo-inositol (8) . There are 3-phytases A (myo-inositol hexakisphosphate 3-phos phohydrolase, EC 3.1.3.8), which start catalytic action at C3 atom of the myo-inositol ring, 6-phytases A (myo-inositol h exaphosphate 6-phosphohydrolase, EC 3.1.3.26), which initiate the hydrolysis at the C6, and phytases B (EC 3.1. 3.2), non -specifi c acid phosphomonoesterases (3) . Generally, p hytases A are not able to hydrolyse phosphate residue at the C2 of the myo-inositol ring. Phytase B, on the other hand, may liberate phosphorus from any position and therefore concurrent action of phytase A and phytase B may lead to almost complete dephosphorylation of phytate, and generation of substantial amounts of myo-inositol (4) . Myo-inositol is hexahydroxylic cyclohexane derivative present in all types of living cells, in concentrations varying from 0.03 mM in human plasma to 3 mM in brain tissue, cerebrospinal fl uid, foetal serum and human milk (9) . The content in human diet oscillates between 0.8 and 1 g per day, more than half of this compound in the form of inositol phospholipids. Decreased levels of myo-inositol are associated with the risk of cataracts, retinopathy, and neuropathy development (10). Studies on rodents and humans demonstrated that myoinositol was eff ective in treating diabetes and may be a suitable marker for mass screening of diabetes, insulin resistance and glucose intolerance (11, 12) . Larner et al. (13) proposed a new model of insulin signalling with inositol glycans as putative second messengers. Kim et al. (14) found this substance to be eff ective in inducing the response of macrophages to bacterial infections and other infl ammatory conditions. Okazaki and Katayama (15) found that myo-inositol prevented accumulation of fat in the liver of rats intoxicated with DDT. This compound also regulates fat metabolism in the myocardium of rats with chemically induced diabetes (16) . Myo-inositol is also known to exert positive eff ects in the treatment of psychiatric disorders (17) , and is also involved in several aspects of human reproduction (18) . Remarkably, some reports indicate that mixtures of myo-inositol and phytate are more eff ective in cancer cell elimination than these substances administered separately (19, 20) . In the literature, there are reports that clearly indicate bioactive properties of this compound, which suggests that supplementation of foods with myo-inositol might be a proper way to modulate sugar and lipid metabolism in humans. The strategy presented here is based on the concept of enzymatic conversion of endogenous phytates of rye fl our into myo-inositol by means of commerci al microbial phytases added to the dough. Although phytase application in the breadmaking has been studied by a few researchers (5) (6) (7) 21) , there is no evidence to suggest that this can be utilized as a method for producing bread with enhanced myo-inositol content.
The objectives of the current study are therefore to assess the impact of the addition of 6-phytase A and phytase B, alone or in combination, to the dough on the bioavailability of myo-inositol from rye bread by an in vitro procedure simulating digestion in human alimentary tract. Also, its bioaccessibility is determined by the measurement of an uptake by the Caco-2 cell monolayer.
Materials and Methods

Enzymes
The preparation of 3-phytase A (Natuphos ® ) was obtained from BASF, Ludwigsh afen, Germany, 6-phytase A (Ronozyme ® NP) was a product of Novozymes, Bag gsvaerd, Denmark, and phytase B (Finase ® AP) of AB Enzymes, Rajam äki, Finland. Pepsin and pancreatin were purchased from Sigma Chemical Co (St. Louis, MO, USA). Acid phosphatase activity was determined at 40 °C by incubating the enzyme with 5.5 mM solution of sodium p-nitrophenylphosphate at pH=4.5 for 15 min. The unit of acid phosphatase activity (APAU) was defi ned as the amount of enzyme which, under the reaction conditions, liberates 1 µmol of p-nitrophenol during 1 min. One unit of phytase A activity (PAU) was defi ned as the amount of enzyme that liberates 1 µM of inorganic phosphorous from 2 mM of sodium phytate in 1 min at 40 °C, pH=4.5.
Breadmaking procedure
Wholemeal rye bread was baked using the following recipe for dough preparation: 1000 g of wholemeal rye fl our type 2000 from Podlaskie Młyny Wodne (Tokary, Poland), 80 g of an acidifi er from Bionat S.A. (Kraków, Poland), 50 g of lyophilized baker's yeast from Lesaff re P.S. (Łódz, Poland) and 30 g of table salt from POCh (Gliwice, Poland) were mixed with 720 mL of tap water. Experimental dough consisted of the above components, but 670 mL of tap water and 50 mL of 0.05 M acetate buff er (pH=4.5) was used. Appropriate amounts of enzyme preparations were diluted in the acetate buff er to obtain 30 APAU or 5000 PAU per kg of fl our. The dough ingredients were mixed for 9 min and then dough pieces of 250 g were form ed, put in metal forms and placed in a fermentation chamber at 35 °C and constant moisture. A er 150 min, fermented dough samples were transferred to an oven preheated to 260 °C. A er 30 min, the loaves were removed from the oven and le for 2 h to cool. Baking procedures were performed in triplicates and included a control bread in each run.
In vitro procedure
Bioavailability of myo-inositol was estimated by an in vitro technique according to the method developed by Zyla et al. (22) and subsequently modifi ed by Starzyńska--Janiszewska et al. (23) to simulate the conditions of human gastrointestinal tract. Half a gram of samples of bread was incubated with 1.7 mg of pepsin (Sigma-Aldrich, Steinheim, Germany; the declared activity was 4750 U/mg) dissolved in 0.1 mol/L HCI at 37 °C, pH=2.0, for 2 h. Next, 2.5 mg of pancreatin (Sigma-Aldrich, from porcine pancreas, 8 × United States Pharmacopeia) dissolved in 0.1 mol/L of NaHCO 3 were added and the whole samples were incubated in dialysis tubes (Sigma-Aldrich, cellulose membrane 25 mm ×16 mm) at 37 °C, pH=7.0, for 4 h. These incubations simulated the digestion in the stomach and small intestine, respectively.
Cell culture
The human colorectal carcinoma cell line, Caco-2, was cultured in Dulbecco's modifi ed Eagle's medium (DMEM) supplemented with 10 % of foetal bovine serum (FBS Gold, PAA Laboratories GmbH, Cölbe, Germany) with antibiotics and antimycotics (PAA Laboratories GmbH). Cultures were passed when they had reached 50 % confl uence and 5·10 5 of cells were seeded on the porous membranes of cell culture inserts (BD Falcon transparent inserts for a 12-well plate, pore diameter 0.4 µm, 1.6·10 6 pores/cm 2 , BD (Becton, Dickinson and Compan y), Franklin Lakes, NJ, USA). The full diff erentiation to enterocyte-like cells was achieved a er sebsequent two weeks of culture. The quality of epithelial layers was regularly monitored by measuring their transepithelial elec-trical resistance (TEER) with epithelial voltohmmeter (EVOM, World Precision Instruments, Sarasota, FL, USA). One day before the experiment, the media were changed to serum-free DMEM (SF-DMEM) supplemented with 0.2 % of bovine serum albumin (BSA) in all wells. Cells were serum-starved for 24 h, then 250 µL of bread dialysates were added to the apical chambers along with 250 µL of SF-DMEM. In the in vitro control treatment, blanks were used instead of a bread dialysate in the in vitro procedure. Basolateral chambers were fi lled with 1 mL of myo-inositol-free SF-DMEM (Institute of Immunology and Experimental Therapy, Wroclaw, Poland). A er 48 h, the media were collected from the basolateral and apical chambers, centrifuged at 1000 ×g for 5 min, and frozen at -80 °C for future analysis.
Chromatographic system and detection
Analysis of myo-inositol phosphates in bread samples
Extraction of inositol phosphates from bread samples was conducted according to Gambuś et al. (24) . Profi les of the isomers of myo-inositol phosphates were analyzed on the Ultimate 3000 system (Dionex Corporation, Sunnyvale, CA, USA) using high-performance anion excha nge chromatography (HPAEC) with postcolumn derivatization and spectrophotometric detection, as described earlier (25) .
Analysis of myo-inositol in dialysates
Chromatograms were generated using HPLC column Rezex ™ RCM Ca 2+ (375 mm × 4 mm i.d., Phenomenex, Torrance, CA, USA ) for comprehensive analysi s of monosaccharides and sugar alcohols fi lled with sulphonated styrene-divinylbenzene beads in cross-linked polymer (8 %) in cationic form (Ca 2+ ). The detection was performed using the pulsed amperometric detector (PAD). Analyses were carried out at 25 °C with fl ow rates of 0.6 mL/min using deionized water as an eluent a er postcolumn modifi cation with sodium hydroxide (200 mM, fl ow rate of 0.15 mL/ min) (26) . The HPLC experiments were done in triplicate.
Analysis of myo-inositol in conditioned cell culture media Chromatograms were generated using Dionex CarboPac™ MA1 HPLC column (250 mm × 4 mm i.d., Dionex Corporation) and the PAD detection system. Analyses were carried out at 25 °C with fl ow rates of 1 mL/min using linear gradient of deionized water and 1 M NaOH as the eluent according to the Dionex AN67 brochure. HPLC experiments were done in triplicates. Two diff erent methods were used in the analysis. The Rezex™ RCM column (Phenomenex) allowed for a be er separation of stereoisomers, chiro-from myo-inositol in the dialysates from the in vitro method, whereas direct detection of myo-inositol on the CarboPac MA1 column by the HPAEC-PAD procedure was more sensitive in the case of myo-inositol determination in the cellular fl uids.
Statistical analysis
Experimental data were subjected to the one-way ana lysis of variance (ANOVA) to detect signifi cant diff erences among the results and expressed as a mean value± standard error of mean (SEM). The signifi cance of diff erences was checked by the Tukey's test using STATISTICA for Windows, v. 10 (StatSo Inc., Tulsa, OK, USA) statistical so ware.
Results and Discussion
Loaves of rye bread baked from dough samples with the addition of either 6-phytase A (5000 PAU per kg of fl our) or phytase B (30 APAU per kg of fl our), or a combination of 6-phytase A with phytase B were analyzed by the in vitro procedure that simulated gastric and intestinal digestion in humans to assess bioavailability of myo-inositol. Signifi cant diff erences among concentrations of dialysable myo-inositol released from bread samples in the in vitro simulation of multiple digestions were observed (Fig. 1) . The generation of myo-inositol in the control bread samples was probably caused by the activity of endogenous phytases from rye and yeast phytases. In samples of control bread baked without enzymes the concentration of dialysable myo-inositol was 25.3 µg/mL, in the dialysates of bread baked with 6-phytase A 35.49 µg/mL, whereas in bread supplemented with phytase B, myo-inositol concentration was almost 2.56-fold higher (64.98 µg/ mL). However, simultaneous application of both phytases during breadmaking (6-phytase A at 5000 PAU per kg of fl our and phytase B at 30 APAU per kg of fl our) did not enhance dialysable myo-inositol (64.04 µg/mL) above the level obtained with phytase B used as a sole supplemental enzyme. Phytase B as unspecifi c acid phosphatase most probably releases phosphates in a random way, proportionally decreasing the level of existing inositol phosphates in rye bread and liberating free myo-inositol. In the presence of phytase A, however, the levels of myo-inositol were not higher and the fi nal products were detected as inositol mono-(IP1) and diphosphates (IP2). In the next step, bioaccessibility of myo-inositol was assessed by measuring the transport of this compound through the monolayer of the Caco-2 cells. Schematic diagram of the cell culture procedure is depicted in Fig. 2 . This cell line derived from colonic adenocarcinoma surprisingly well mimics intestinal cell behaviour upon long culture. The fortnight culture of these cells on porous membranes of inserts leads to the creation of an impervious epithelial layer of polarized cells which resemble mature enterocytes (27) . Tissue culture tests provide a relatively quick and cost-eff ective tool for predicting the absorption of bioactive components by assessing the probability of their transport through epithelial layer (28).
These tests are o en a reasonable alternative to in vivo studies on laboratory animals (e.g. rats) in the analysis of the phytate conversion; however, it should be taken into account that phytase activity in rodent small intestine is 30-fold higher than in human tissue. In the control experiment three concentrations of myo-inositol were used (0, 25 and 50 µg/mL) to demonstrate a relationship between the myo-inositol transport rate and its concentration (Fig. 3) . The uptake of myo-inositol by Caco-2 cell line was found to depend on the myo-insoitol concentration, which is in agreement with the literature data describing two main sodium/myo-inositol cotransporters (29) . The fl uid from basolateral chambers of inserts from Caco-2 monolayers exposed for 48 h to the digest of bread supplemented with phytase B and the fl uid from the same chamber before the addition of the digest were analyzed. Caco-2 cells exposed to the dialysates from digests of bread absorbed myo-inositol from the apical chambers and then secreted it to the basolateral chambers of the inserts.
To our knowledge, this is the fi rst evidence of myo--inositol transport across Caco-2 monolayers. The amounts of myo-inositol secreted to the basolateral chambers from the inserts not exposed (control in vitro) and exposed to the bread digests for 48 h, also expressed as a percentage of the initial amounts of myo-inositol in apical chambers, are given in Table 1 . Total amounts of myo-inositol determined in both the apical and the basolateral chambers at the beginning of the experiment were subtracted from the total amounts of this compound determined a er 48 h of the Caco-2 cell culture.
The initial myo-inositol amounts in the apical chambers diff ered among treatments because a standardized volume of 0.25 mL of the bread digests or of the reagents used in the in vitro procedure (the control in vitro treatment), mixed with 0.25 mL of the DMEM solution, was applied on the inserts. Generally, no close relationship was found between myo-inositol amounts in the apical and basolateral chambers of the inserts, which may suggest that specifi c transport mechanisms rather than passive diff usion phenomena were active in the myo-inositol monolayer metabolism. The highest amounts of myo-inositol were released from the Caco-2 cells immersed in the digests of bread modifi ed with the addition of 6-phytase A, whereas signifi cantly lower amounts of this compound were determined in the basolateral chambers of inserts fi lled with the dialysate of bread made with phytase B. The amounts of myo-inositol determined in the basolater- Fig. 2 . Schematic diagram of the cell culture. Caco-2 cells were cultured for two weeks on the porous membrane which separates apical and basolateral chambers of the insert to obtain continuous monolayer of diff erentiated cells. Myo-inositol or dialysates of bread were added from the apical side diluted (1:1) in 0.5 mL of myo-inositol-free SF-DMEM medium. A volume of 1 mL of myo-inositol-free DMEM medium was poured into the basolateral part. A er 48 h the media were collected from both chambers to estimate the paracellular fl ow of myoinositol. The consistence of monolayers was monitored by measuring the TEER values at the beginning and the end of incubation period. TEER=trans epi thelial electrical resistance al chambers a er 48 h of Caco-2 culture accounted for 123 %, and for 61 % of its initial amounts in the apical chambers fi lled with the digests of bread made with the addition of 6-phytase A, and phytase B, respectively.
It se ems possible that Caco-2 cells dephosphorylated myo-inositol phosphate intermediates generated by 6-phytase A, but were unable to degrade lower myo-inositol phosphates produced by the catalytic action of phytase B. Such hypothesis should be considered because these enzymes are known to release two distinct pools of myo--inositol phosphates during their action on myo-inositol hexa kisphosphates (phytates). The profi les of myo-inositol phos phates analyzed by HPAEC in the enzyme-modifi ed bread shown in Table 2 may serve as a confi rmation of the hypothesis mentioned above. In bread supplemented with phytase B the main fraction is inositol phosphate with 3 to 4 phosphorus moieties, but in the bread made with the addition of 6-phytase A, these were inositol diand triphosphates. The application of both phytases resulted in bread samples whose digests infl uenced Caco-2 metabolism similarly as in the case of bread baked with phytase B alone. The explanation of this phenomenon is similar to the situation observed in determination of myoinositol in bread subjected to in vitro procedure.
An additional evidence of a substantial diff erence in myo-inositol metabolism in Caco-2 cells subjected to digests from the bread supplemented with 6-phytase A and that supplemented with phytase B is provided in Fig. 4 , where the net changes in myo-inositol mass in both apical and basolateral chambers of the inserts in the course of 48-hour culture are shown. In the in vitro control, control bread and 6-phytase A treatments, myo-inositol was synthesised by the Caco-2 cells most probably due to the action of cellular phosphatases on lower myo-inositol phosphates, but in the treatments where the digest contained the products of phytase B, myo-inositol consumption or degradation was evidenced. It can be postulated, therefore, that in contrast to 6-phytase A, the action of phytase B on the dough components of rye bread must have produced compounds which negatively aff ected myo-inositol bioaccessibility.
While phytase B seems to be the key activity that determines myo-inositol bioavailability from rye bread, 6-phytase A caused the highest enhancement in its bioaccessibility. Suzuki et al. (30) observed that phytate hydrolysates, especially myo-inositol triphosphates, were able to induce intracellular signalling in the Caco-2 cell line, and myo-inositol phosphate synthase (MIPS) is known to be regulated by phosphorylation (31) . It could not be excluded that physiologically benefi cial distribution of myo--inositol triphosphates generated by 6-phytase A stimulated Caco-2 cells to synthesize and eff ectivelly secrete myo-inositol, thus enhancing its bioaccessibility. Shockravi et al. (21) studied iron and zinc bioaccessibility from breads made from fl our with diff erent extraction rates and dephytinized by Aspergillus niger 3-phytase A during in vitro digestion. As a result of phytase application, they reported substantial improvements in bioaccessibility of iron and zinc determined in the Caco-2 cell line.
The current study confi rms that myo-inositol is released during hydrolysis of fl our phytates in this individual bread-making process more effi ciently by phytase B than by 6-phytase A. The 6-phytase A, however, generates myo-inositol which is signifi cantly more bioaccessible. Myo --inositol is known to exert multiple physiological eff ects that are manifested by antioxidant, immunostimulating and antidepressant properties (9, 32) . Many important questions regarding dephosphorylation of phytases in cereals have not been addressed yet. This study contributes to the development of an entirely new and innovative approach in breadmaking, involving the enzymatic conversion of phytates, which have antinutritional properties, into myo-inositol -a biostimulating and health-promoting compound.
Conclusions
The application of proper phytate-degrading enzymes in the technology of rye breadmaking leads to gen- Fig. 4 . Myo-inositol balance a er 48 h of culture of the Caco-2 monolayers. Total amounts of myo-inositol determined in both the apical and the basolateral chambers at the beginning of the experiment were subtracted from the total amounts of this compound determined a er 48 h of the Caco-2 cell culture. In vitro control=culture medium without bread sample addition, control bread=rye bread made without enzyme addition, 6-phytase A=bread supplemented with 6-phytase A at 5000 PAU per kg of fl our, phytase B=bread supplemented with phytase B at 30 APAU per kg of fl our, phytase B+6 phytase A=rye bread supplemented with both phytases. Signifi cant diff erences between the fi nal and initial myo-inositol mass at *p<0.01 and **p<0.001 eration of myo-inositol -a component with bioactive, health-promoting eff ects. Its actions include insulin sensitivity modulation, regulation of cholesterol metabolism, central nervous and reproduction system development and maintenance, as well as regulation of the bone calcification processes. Simultaneous application of phytase A and phytase B or phytase B alone to the dough leads to the release of 2.4-fold higher amounts of bioavailable myo-inositol, as assessed by an in vitro procedure which simulates digestion in the human intestine. Determination of bioaccessibility of this compound by the measurement of an uptake by Caco-2 cell monolayer revealed that 6-phytase A was the most eff ective enzyme in enhancing the amount of bioaccessible myo-inositol in the experimental bread. Enzymatically modifi ed rye bread may therefore be a rich source of bioavailable and bioaccessible myo-inositol. Enzymatic generation of myo-inositol seems to be a promissing alternative to a strategy of food supplementation with health-promoting components.
